Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Transmembrane protein 141 (TMEM141) is a small, multi-pass integral membrane protein encoded by the TMEM141 gene in humans (UniProt Q96I45), with a molecular mass of ~11.9 kDa. It is mainly localized to the mitochondrion and expressed in various tissues, with notable abundance in endothelial cells, neurons, and most glandular tissues. Orthologs exist in model organisms (e.g., Drosophila), sharing mitochondrial localization. TMEM141’s function remains uncharacterized: no established role in signal transduction, cell cycle, or other canonical membrane protein functions has been reported. Although related TMEM family genes have been implicated in cancer and immune regulation, there is no evidence that TMEM141 directly participates in those processes. Rare biallelic loss-of-function variants can cause neurodevelopmental disorders in humans, and Mendelian disease association includes arthrogryposis multiplex congenita-3. No currently approved or investigational drugs target TMEM141, and it is not used as a diagnostic or predictive biomarker.
Not applicable
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Transmembrane protein 141 (TMEM141).